Wedbush Securities’s Psychemedics Corporation PMD Stock Holding History

Wedbush Securities’s Portfolio PMD Stock Details PMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-47,868	Closed	-$111K	–	1212
2024 Q3	$111K	Sell	47,868 -2,473	-5%	-$5.56K	﹤0.01%	1050
2024 Q2	$122K	Sell	50,341 -102	-0.2%	-$259	﹤0.01%	1131
2024 Q1	$148K	Buy	50,443 +1,779	+4%	+$5.64K	0.01%	1146
2023 Q4	$144K	Buy	48,664 +6,250	+15%	+$16.7K	0.01%	1009
2023 Q3	$168K	Buy	42,414 +8,257	+24%	+$36.8K	0.01%	944
2023 Q2	$156K	Buy	34,157 +4,739	+16%	+$24K	0.01%	970
2023 Q1	$154K	Sell	29,418 -1,510	-5%	-$8.37K	0.01%	978
2022 Q4	$152K	Buy	30,928 +11,135	+56%	+$65.7K	0.01%	947
2022 Q3	$128K	Buy	+19,793	New	+$127K	0.01%	952

Other funds holding PMD

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

CSC

Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return

SMP

Santa Monica Partners Palm Beach Gardens, Florida $179M AUM 19.18% 1-Year Est. Return

Wedbush Securities's PMD Position: Q4 2024 in Review

Wedbush Securities sold out of Psychemedics Corporation (PMD) in Q4 2024, closing a stake of 47,868 shares — an estimated $111K sold.

Wedbush Securities first reported a position in PMD in Q3 2022 and held it in 9 quarters. The position peaked at $168K in Q3 2023. 3 funds tracked by Wall St. Rank hold PMD as of Q4 2024.

Wedbush Securities reported no remaining Psychemedics Corporation position as of Q4 2024 after selling out during the quarter.
Wedbush Securities sold 47,868 Psychemedics Corporation shares in Q4 2024, an estimated $111K.
Wedbush Securities first reported a position in Psychemedics Corporation in Q3 2022 and held it in 9 quarters.
Wedbush Securities's Psychemedics Corporation position peaked at $168K in Q3 2023.
3 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2024.

Based on Wedbush Securities's 13F filing for Q4 2024, filed 13 Feb 2025.